Lindbrook Capital, LLC Avrobio, Inc. Transaction History

Lindbrook Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$5.53 - $9.28 $530 - $890	-96 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$7.84 - $12.6 $752 - $1,209	96 New	96 $1,000
Q4 2020 Jan 27, 2021	SELL	$12.79 - $17.1 $102 - $136	-8 Closed	0 $0
Q3 2020 Nov 03, 2020	SELL	$12.99 - $19.41 $727 - $1,086	-56 Reduced 87.5%	8 $0
Q2 2020 Jul 27, 2020	BUY	$12.19 - $22.96 $341 - $642	28 Added 77.78%	64 $1,000
Q1 2020 Apr 22, 2020	BUY	$10.08 - $27.21 $362 - $979	36 New	36 $1,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.